Estonia · Delayed Price · Currency is EUR Ligand Pharmaceuticals Statistics
Total Valuation
TAL:TAL1T has a market cap or net worth of EUR 454.32 million. The enterprise value is 914.02 million.
| Market Cap | 454.32M |
| Enterprise Value | 914.02M |
Important Dates
The last earnings date was Friday, July 25, 2025.
| Earnings Date | Jul 25, 2025 |
| Ex-Dividend Date | Nov 13, 2025 |
Share Statistics
TAL:TAL1T has 743.57 million shares outstanding. The number of shares has decreased by -0.28% in one year.
| Current Share Class | 743.57M |
| Shares Outstanding | 743.57M |
| Shares Change (YoY) | -0.28% |
| Shares Change (QoQ) | +0.58% |
| Owned by Insiders (%) | 3.76% |
| Owned by Institutions (%) | 13.52% |
| Float | 86.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.60 |
| PB Ratio | 0.65 |
| P/TBV Ratio | 0.67 |
| P/FCF Ratio | 4.56 |
| P/OCF Ratio | 3.42 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.39, with an EV/FCF ratio of 9.18.
| EV / Earnings | -223.42 |
| EV / Sales | 1.20 |
| EV / EBITDA | 8.39 |
| EV / EBIT | 65.11 |
| EV / FCF | 9.18 |
Financial Position
The company has a current ratio of 0.48, with a Debt / Equity ratio of 0.71.
| Current Ratio | 0.48 |
| Quick Ratio | 0.25 |
| Debt / Equity | 0.71 |
| Debt / EBITDA | 4.55 |
| Debt / FCF | 4.98 |
| Interest Coverage | 0.54 |
Financial Efficiency
Return on equity (ROE) is -0.56% and return on invested capital (ROIC) is 0.68%.
| Return on Equity (ROE) | -0.56% |
| Return on Assets (ROA) | 0.59% |
| Return on Invested Capital (ROIC) | 0.68% |
| Return on Capital Employed (ROCE) | 1.26% |
| Revenue Per Employee | 143,294 |
| Profits Per Employee | -772 |
| Employee Count | 4,448 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 13.39 |
Taxes
In the past 12 months, TAL:TAL1T has paid 11.36 million in taxes.
| Income Tax | 11.36M |
| Effective Tax Rate | 156.25% |
Stock Price Statistics
The stock price has increased by +6.23% in the last 52 weeks. The beta is 0.40, so TAL:TAL1T's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | +6.23% |
| 50-Day Moving Average | 0.64 |
| 200-Day Moving Average | 0.62 |
| Relative Strength Index (RSI) | 27.66 |
| Average Volume (20 Days) | 118,584 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TAL:TAL1T had revenue of EUR 759.60 million and -4.09 million in losses. Loss per share was -0.01.
| Revenue | 759.60M |
| Gross Profit | 127.26M |
| Operating Income | 14.04M |
| Pretax Income | 7.27M |
| Net Income | -4.09M |
| EBITDA | 90.26M |
| EBIT | 14.04M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 35.98 million in cash and 495.68 million in debt, giving a net cash position of -459.70 million or -0.62 per share.
| Cash & Cash Equivalents | 35.98M |
| Total Debt | 495.68M |
| Net Cash | -459.70M |
| Net Cash Per Share | -0.62 |
| Equity (Book Value) | 698.11M |
| Book Value Per Share | 0.94 |
| Working Capital | -156.35M |
Cash Flow
In the last 12 months, operating cash flow was 132.81 million and capital expenditures -33.20 million, giving a free cash flow of 99.61 million.
| Operating Cash Flow | 132.81M |
| Capital Expenditures | -33.20M |
| Free Cash Flow | 99.61M |
| FCF Per Share | 0.13 |
Margins
Gross margin is 16.75%, with operating and profit margins of 1.85% and -0.54%.
| Gross Margin | 16.75% |
| Operating Margin | 1.85% |
| Pretax Margin | 0.96% |
| Profit Margin | -0.54% |
| EBITDA Margin | 11.88% |
| EBIT Margin | 1.85% |
| FCF Margin | 13.11% |
Dividends & Yields
This stock pays an annual dividend of 0.06, which amounts to a dividend yield of 9.77%.
| Dividend Per Share | 0.06 |
| Dividend Yield | 9.77% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.28% |
| Shareholder Yield | 10.05% |
| Earnings Yield | -0.90% |
| FCF Yield | 21.92% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 26, 2007. It was a forward split with a ratio of 4.
| Last Split Date | Jan 26, 2007 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
TAL:TAL1T has an Altman Z-Score of 1.14 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.14 |
| Piotroski F-Score | 5 |